Skip to content

Do Oral Contraceptives Protect Against ACL Injuries in Female Athletes

Do Oral Contraceptives Protect Against Anterior Cruciate Ligament Injuries in Female Athletes

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04899778
Acronym
OC
Enrollment
73
Registered
2021-05-24
Start date
2021-09-29
Completion date
2024-06-30
Last updated
2026-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ligament Injury

Keywords

anterior cruciate ligament, birth control, oral contraceptive

Brief summary

The purpose of this research study is to examine the impact of one type of commonly used birth control pill on blood levels of relaxin and measure changes in knee movement to determine whether there are changes in joint instability (indicating the knee is less stable) that may predispose female athletes to injury. Women not on hormonal birth control will also be enrolled to analyze differences between athletes on and not on birth control and to evaluate typical relaxin levels and knee laxity when birth control pills are not used.

Interventions

DRUGOral Contraceptive Pill, norethindrn a-e estradiol-iron

tablet

Sponsors

Cedars-Sinai Medical Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Female * 18 years of age or older * Currently playing basketball, soccer, or volleyball at Loyola Marymount or Pepperdine * If not currently on COC, regular menstrual cycle occurring every 21-35 days

Exclusion criteria

* Previous ACL injury * Underlying neuromuscular disease * Medical contraindication to COC use * History of pregnancy * Desire to conceive in the next year

Design outcomes

Primary

MeasureTime frameDescription
Injuryover the course of 1 yearAny injury resulting in time away from practice or competition

Secondary

MeasureTime frameDescription
Serum Relaxin Levelbaselinelevel of relaxin measured in each subject
Anterior Knee LaxitybaselineAnterior Knee laxity will be evaluated using the KT-2000 and measured in millimeters of anterior translation of the tibia relative to the femur
Hip Flexion at Initial Contact During a Single-legged DropbaselineHip flexion measured during a singled-legged drop using motion tracking equipment.
Knee Adduction Rotation During a Single-legged Dropbaselineinward rotation of the knee during max knee flexion measured during a singled-legged drop using motion tracking equipment.
Joint HypermobilitybaselineBeighton score will be used to assess overall joint laxity. The Beighton score is on a nine-point scale that is based on 5 joint maneuvers. The maximum score is 9, which indicates increased laxity in the joints. A score of zero indicates inflexible joints.

Countries

United States

Participant flow

Participants by arm

ArmCount
OCs Users
Participant athletes regularly took oral contraceptives or had a hormone-containing IUD.
31
Non-OCs
Participant athletes were not on any form of contraception.
42
Total73

Baseline characteristics

CharacteristicOCs UsersNon-OCsTotal
Age, Categorical
<=18 years
1 Participants2 Participants3 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants40 Participants70 Participants
Age, Continuous21.3 years
STANDARD_DEVIATION 3.3
21.9 years
STANDARD_DEVIATION 3.7
21.6 years
STANDARD_DEVIATION 3.5
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
31 Participants42 Participants73 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 310 / 42
other
Total, other adverse events
0 / 310 / 42
serious
Total, serious adverse events
0 / 310 / 42

Outcome results

Primary

Injury

Any injury resulting in time away from practice or competition

Time frame: over the course of 1 year

Population: collegiate and professional female athletes

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Oral Contraceptive PillInjury8 Participants
No Oral ContraceptiveInjury16 Participants
Secondary

Anterior Knee Laxity

Anterior Knee laxity will be evaluated using the KT-2000 and measured in millimeters of anterior translation of the tibia relative to the femur

Time frame: baseline, 4 month visit

Secondary

Hip Rotation During a Single-legged Drop

Hip flexion, adduction, and internal/external and coronal plane rotation of the knee measured during a singled-legged drop using motion tracking equipment.

Time frame: baseline, 4 month visit

Secondary

Joint Hypermobility

Beighton score will be used to assess overall joint laxity. The Beighton score is on a nine-point scale that is based on 5 joint maneuvers. The maximum score is 9, which indicates increased laxity in the joints. A score of zero indicates inflexible joints.

Time frame: baseline, 4 month visit

Secondary

Knee Rotation During a Single-legged Drop

Hip flexion, adduction, and internal/external and coronal plane rotation of the knee measured during a singled-legged drop using motion tracking equipment.

Time frame: baseline, 4 month visit

Secondary

Serum Relaxin Level

level of relaxin measured in each subject

Time frame: baseline, 4 month visit

Source: ClinicalTrials.gov · Data processed: Sep 10, 2026